InsidersTradesSigma
Follow the 삼양바이오팜 stock price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are listed on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 삼양바이오팜 has recorded 1 reports. Market capitalisation: €282.6bn. The latest transaction was filed on 4 March 2026 (Other). Among the most active insiders: 김윤. All data is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Samyang Biopharm is a company in the health and pharmaceutical sector, listed on the XKRX market. It specializes in the development of innovative pharmaceutical products.